Literature DB >> 12082628

TERT regulates cell survival independent of telomerase enzymatic activity.

Ying Cao1, He Li, Siddhartha Deb, Jun-Ping Liu.   

Abstract

Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, plays a pivotal role in the maintenance of telomeres and cell proliferation. Here we report that down-regulation of hTERT induces apoptosis independently of telomerase enzymatic activity in human breast cancer cells. Expression of a hTERT mutant lacking telomerase activity rescues the cells with lowered telomerase without inducing cell death. With similar patterns of subcellular distribution to that of the tumor suppressor protein p53 during mitosis, hTERT interacts with p53 and poly(ADP-ribose) polymerase (PARP). Decreasing p53 expression in intact cells worsens, and increasing p53 prevents, cell death induced by lowering hTERT. Thus, hTERT maintains cell survival and proliferation via both telomerase enzymatic activity-dependent telomere lengthening and enzymatic activity-independent intermolecular interactions involving p53 and PARP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082628     DOI: 10.1038/sj.onc.1205419

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

1.  Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.

Authors:  Enrica Rampazzo; Laura Bonaldi; Livio Trentin; Carlo Visco; Sonia Keppel; Silvia Giunco; Federica Frezzato; Monica Facco; Elisabetta Novella; Ilaria Giaretta; Paola Del Bianco; Gianpietro Semenzato; Anita De Rossi
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

Review 2.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

3.  PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres.

Authors:  Marla Gomez; Jun Wu; Valérie Schreiber; John Dunlap; Françoise Dantzer; Yisong Wang; Yie Liu
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

4.  Telomerase is involved in IL-7-mediated differential survival of naive and memory CD4+ T cells.

Authors:  Yinhua Yang; Jie An; Nan-ping Weng
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

5.  The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.

Authors:  Nathan J Hansen; Rebecca C Wylie; Sharla M O Phipps; William K Love; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

6.  Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro.

Authors:  Haibo Tang; Linhu Ge; Wenlong Shao; Yuan Qiu; Dong Cui
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

7.  Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice.

Authors:  Jieli Chen; Alex Zacharek; Chunling Zhang; Hao Jiang; Yi Li; Cynthia Roberts; Mei Lu; Alissa Kapke; Michael Chopp
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

Review 8.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

9.  The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.

Authors:  Imke Listerman; Jie Sun; Francesca S Gazzaniga; Jason L Lukas; Elizabeth H Blackburn
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

10.  Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.

Authors:  Dakang Xu; Julie Dwyer; He Li; Wei Duan; Jun-Ping Liu
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.